Apomorphine in Severe Brain-injured Patients
Apomorphine in Severe Brain-injured Patients
Recruiting · NCT05213169 · Registry updated 2025-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Apomorphine in Severe Brain-injured Patients | Brain Damage, Chronic, Consciousness Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Persistent Vegetative State, Signs and Symptoms, Unconsciousness, brain disorder, central nervous system disorder, cognitive disorder, nervous system disorder, psychiatric disorder | Recruiting | Phase 2 / Phase 3 | 2025-04-15 | NCT05213169 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Neurologique William Lennox | Ottignies-Louvain-la-Neuve | Belgium | 1 |
| Hôpital Valdor - ISoSL | Liège | Belgium | 1 |
| University of Liege | Liège | Belgium | 2 |
| VITHAS | Valencia | Spain | 1 |